EBITDA: Income before interest, taxes, depreciation and amortization.
Exagen Inc. (XGN) had EBITDA of $-10.84M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$66.58M |
|
$-19.95M |
|
$27.78M |
|
$38.80M |
|
$80.64M |
|
$-14.07M |
|
$-5.83M |
|
$-19.90M |
|
$-19.90M |
|
$-19.95M |
|
$-19.95M |
|
$-19.95M |
|
$-19.95M |
|
$-14.07M |
|
|
EBITDA |
$-10.84M |
21.56M |
|
21.56M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$48.89M |
|
$6.94M |
|
$9.13M |
|
$58.02M |
|
$14.16M |
|
$24.22M |
|
$26.41M |
|
$40.57M |
|
$17.45M |
|
$17.45M |
|
$17.45M |
|
22.91M |
|
| Cash Flow Statement Financials | |
$-13.62M |
|
$-0.63M |
|
$24.43M |
|
$22.24M |
|
$32.42M |
|
$10.18M |
|
$2.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
0.58 |
|
1.49 |
|
58.28% |
|
-21.13% |
|
-21.13% |
|
-16.28% |
|
-29.89% |
|
-29.97% |
|
$-14.25M |
|
-- |
|
-- |
|
-- |
|
1.15 |
|
-- |
|
6.13 |
|
59.51 |
|
-114.34% |
|
-114.34% |
|
-34.39% |
|
-47.88% |
|
$0.76 |
|
$-0.66 |
|
$-0.63 |
|